|
Avaliação DCF Inspiremd, Inc. (NSPR)
IL | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
InspireMD, Inc. (NSPR) Bundle
Explore a perspectiva financeira da Explore Inspiremd, Inc. (NSPR) com nossa calculadora DCF amigável! Digite suas projeções de crescimento, margens e despesas para descobrir o valor intrínseco da InspirEmd, Inc. (NSPR) e informar suas decisões de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.7 | 2.5 | 4.5 | 5.2 | 6.2 | 7.5 | 9.0 | 10.9 | 13.2 | 15.9 |
| Revenue Growth, % | 0 | -33.22 | 80.89 | 15.04 | 20 | 20.68 | 20.68 | 20.68 | 20.68 | 20.68 |
| EBITDA | -9.9 | -10.4 | -14.6 | -18.5 | -20.9 | -7.5 | -9.0 | -10.9 | -13.2 | -15.9 |
| EBITDA, % | -264.93 | -418.07 | -323.8 | -358.25 | -337 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .2 | .2 | .2 | .2 | .2 | .3 | .4 | .5 | .6 | .7 |
| Depreciation, % | 4.25 | 6.08 | 3.58 | 3.64 | 3.74 | 4.26 | 4.26 | 4.26 | 4.26 | 4.26 |
| EBIT | -10.0 | -10.5 | -14.7 | -18.7 | -21.1 | -7.5 | -9.0 | -10.9 | -13.2 | -15.9 |
| EBIT, % | -269.17 | -424.14 | -327.39 | -361.88 | -340.74 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 5.5 | 12.6 | 34.0 | 17.8 | 39.0 | 7.5 | 9.0 | 10.9 | 13.2 | 15.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.0 | .9 | 1.4 | 1.2 | 2.5 | 2.4 | 2.9 | 3.5 | 4.2 | 5.0 |
| Account Receivables, % | 26.15 | 38.03 | 30.9 | 24.12 | 39.52 | 31.74 | 31.74 | 31.74 | 31.74 | 31.74 |
| Inventories | 1.2 | 1.4 | 1.1 | 1.6 | 2.1 | 2.7 | 3.3 | 3.9 | 4.8 | 5.7 |
| Inventories, % | 33.22 | 56.94 | 25.43 | 31.35 | 33.94 | 36.18 | 36.18 | 36.18 | 36.18 | 36.18 |
| Accounts Payable | .6 | .2 | .9 | .7 | .9 | 1.1 | 1.3 | 1.6 | 2.0 | 2.4 |
| Accounts Payable, % | 17.36 | 9.5 | 19.87 | 12.74 | 15.13 | 14.92 | 14.92 | 14.92 | 14.92 | 14.92 |
| Capital Expenditure | -.3 | -.1 | -.3 | -.5 | -.4 | -.5 | -.6 | -.7 | -.9 | -1.1 |
| Capital Expenditure, % | -7.63 | -3.54 | -7.65 | -9.15 | -6.14 | -6.82 | -6.82 | -6.82 | -6.82 | -6.82 |
| Tax Rate, % | -0.32744 | -0.32744 | -0.32744 | -0.32744 | -0.32744 | -0.32744 | -0.32744 | -0.32744 | -0.32744 | -0.32744 |
| EBITAT | -10.0 | -10.5 | -14.8 | -18.7 | -21.2 | -7.5 | -9.0 | -10.9 | -13.2 | -15.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -11.7 | -11.0 | -14.5 | -19.6 | -22.8 | -8.0 | -10.1 | -12.2 | -14.7 | -17.7 |
| WACC, % | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 | 8.64 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -47.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -18 | |||||||||
| Terminal Value | -272 | |||||||||
| Present Terminal Value | -180 | |||||||||
| Enterprise Value | -228 | |||||||||
| Net Debt | -8 | |||||||||
| Equity Value | -220 | |||||||||
| Diluted Shares Outstanding, MM | 24 | |||||||||
| Equity Value Per Share | -9.05 |
What You Will Get
- Real InspireMD Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for InspireMD, Inc. (NSPR).
- Full Customization: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates specific to InspireMD.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on InspireMD’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for InspireMD, Inc. (NSPR).
- Time-Saving and Accurate: Skip building models from scratch while ensuring precision and flexibility for InspireMD.
Key Features
- Comprehensive Historical Data: InspireMD's (NSPR) past financial reports and projected forecasts included.
- Customizable Parameters: Adjust discount rates, tax percentages, revenue growth, and profit margins as needed.
- Real-Time Analysis: View InspireMD's intrinsic value updating instantly.
- Intuitive Visual Representations: Interactive charts showcase valuation outcomes and essential metrics.
- Designed for Precision: A reliable resource tailored for analysts, investors, and financial professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based InspireMD, Inc. (NSPR) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates InspireMD, Inc.'s (NSPR) intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis decisions.
Why Choose InspireMD's Calculator?
- Precision: Utilizes real InspireMD financials for reliable data accuracy.
- Adaptability: Built for users to experiment and adjust inputs with ease.
- Efficiency: Bypass the complexity of creating a DCF model from the ground up.
- Expert-Level: Crafted with the precision and usability expected by CFOs.
- Intuitive: Simple to navigate, even for those lacking advanced financial modeling skills.
Who Should Use InspireMD, Inc. (NSPR)?
- Medical Device Investors: Develop comprehensive and reliable valuation models for investment analysis in the medical technology sector.
- Healthcare Finance Teams: Evaluate valuation scenarios to inform strategic decisions within healthcare organizations.
- Consultants and Advisors: Offer clients precise valuation insights for InspireMD, Inc. (NSPR) and similar companies.
- Students and Educators: Utilize real-world data to learn and teach financial modeling in the context of medical devices.
- Healthcare Technology Enthusiasts: Gain insights into how companies like InspireMD, Inc. (NSPR) are valued in the healthcare market.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
- Real-World Data: InspireMD, Inc.'s (NSPR) historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.